Taiho Pharma Eyes Global Development of Anticancer Agent S-1

摘要

Taiho Pharmaceutical is planning the global development of anticancer agent S-1 (sold in Japan under the name TS-1);the company will first carry out a series of combination treatment tests in the U.S.,targeting stomach cancer.